López-Mejías Raquel, Genre Fernanda, García-Bermúdez Mercedes, Ubilla Begoña, Castañeda Santos, Llorca Javier, González-Juanatey Carlos, Corrales Alfonso, Miranda-Filloy José A, Pina Trinitario, Gómez-Vaquero Carmen, Rodríguez-Rodríguez Luis, Fernández-Gutiérrez Benjamín, Balsa Alejandro, Pascual-Salcedo Dora, López-Longo Francisco J, Carreira Patricia, Blanco Ricardo, Martín Javier, González-Gay Miguel A
Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Avenida Cardenal Herrera Oria s/n, 39011 Santander, Spain.
Institute of Parasitología and Biomedicina López-Neyra, IPBLN-CSIC, Parque Tecnológico de Ciencias de la Salud, Avenida del Conocimiento s/n, Armilla, 18100 Granada, Spain.
Mediators Inflamm. 2014;2014:756279. doi: 10.1155/2014/756279. Epub 2014 Mar 25.
Rheumatoid arthritis (RA) is a polygenic disease associated with accelerated atherosclerosis and increased cardiovascular (CV) mortality. Recent studies have identified the ABO rs579459, PPAP2B rs17114036, and ADAMTS7 rs3825807 polymorphisms as genetic variants associated with coronary artery disease and the PIK3CG rs17398575 and EDNRA rs1878406 polymorphisms as the most significant signals related to the presence of carotid plaque in nonrheumatic Caucasian individuals. Accordingly, we evaluated the potential relationship between these 5 polymorphisms and subclinical atherosclerosis (assessed by carotid intima-media thickness (cIMT) and presence/absence of carotid plaques) and CV disease in RA.
2140 Spanish RA patients were genotyped for the 5 polymorphisms by TaqMan assays. Subclinical atherosclerosis was evaluated in 620 of these patients by carotid ultrasonography technology.
No statistically significant differences were found when each polymorphism was assessed according to cIMT values and presence/absence of carotid plaques in RA, after adjusting the results for potential confounders. Moreover, no significant differences were obtained when RA patients were stratified according to the presence/absence of CV disease after adjusting for potential confounders.
Our results do not confirm association between ABO rs579459, PPAP2B rs17114036, ADAMTS7 rs3825807, PIK3CG rs17398575, and EDNRA rs1878406 and subclinical atherosclerosis and CV disease in RA.
类风湿性关节炎(RA)是一种多基因疾病,与动脉粥样硬化加速和心血管(CV)死亡率增加相关。最近的研究已确定ABO rs579459、PPAP2B rs17114036和ADAMTS7 rs3825807多态性为与冠状动脉疾病相关的基因变异,以及PIK3CG rs17398575和EDNRA rs1878406多态性为非风湿性白种人个体中与颈动脉斑块存在相关的最显著信号。因此,我们评估了这5种多态性与RA患者亚临床动脉粥样硬化(通过颈动脉内膜中层厚度(cIMT)和颈动脉斑块的有无进行评估)及心血管疾病之间的潜在关系。
通过TaqMan分析对2140名西班牙RA患者的5种多态性进行基因分型。其中620名患者通过颈动脉超声技术评估亚临床动脉粥样硬化。
在对潜在混杂因素进行结果调整后,根据RA患者的cIMT值和颈动脉斑块的有无对每种多态性进行评估时,未发现统计学上的显著差异。此外,在对潜在混杂因素进行调整后,根据心血管疾病的有无对RA患者进行分层时,也未获得显著差异。
我们的结果未证实ABO rs579459、PPAP2B rs17114036、ADAMTS7 rs3825807、PIK3CG rs17398575和EDNRA rs1878406与RA患者亚临床动脉粥样硬化及心血管疾病之间存在关联。